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Abstracts
Novel aNtIfIbRotIc taRgetS
Jörg Distler 
Department of Internal Medicine 3, University of Erlangen-Nuremberg, Germany
Persistent activation of fibroblasts is a common denominator 
of fibrotic diseases but mechanistically incompletely defined. 
In contrast to physiologic tissue repair responses, fibroblasts 
remain persistently active in fibrotic diseases and continue 
to release excessive amounts of extracellular matrix. While fi-
broblast-to-myofibroblast transition occurs only transiently 
increased in normal wound healing and is terminated as soon 
as the damage is repaired, fibroblasts remain persistently active 
in fibrotic diseases. We will discuss the latest approval relevant 
clinical trials for the treatment of fibrosis in systemic sclerosis 
(SSc). Moreover, we will highlight promising preclinical targets 
with high translational potential for the treatment of fibrosis in 
SSc and other fibrotic conditions.
dIagNoSIS aNd tReatmeNt of deRmatomyoSItIS:  
State-of-the aRt
Victoria P. Werth
Division of Dermatology at the Philadelphia Veterans Administration Hospital, 
United States
The Bohan and Peter’s criteria defined dermatomyositis (DM) 
for many years. These criteria did not allow recognition of 
amyopathic DM patients, since patients have to have some 
muscle abnormalities to be recognized as even possible 
DM. Sontheimer’s criteria for the skin findings of DM include 
pathognomonic findings of Gottron’s papules and Gottron’s sign. 
Characteristic findings include heliotrope, periungual telangi-
ectasias, dystrophic cuticles, and photodistributed violaceous 
erythema. Secondary skin features of DM include subepidermal 
vesicle and/or blisters which could evolve into superficial ero-
sion/ulcerations. Other secondary features include vasculopa-
thy, poikiloderma (hyperpigmentation and hypopigmentation, 
telangiectasias, and superficial atrophy), as well as cutaneous 
calcinosis. The International Myositis Classification Criteria Proj-
ect (IMCCP) utilized a collaborative and scientific approach to 
develop criteria that would allow recognition of amyopathic 
DM, with three skin criteria determined as important to include 
as criteria: heliotrope, gottron’s papules, and gottron’s sign. The 
presence of two of the three skin variables allowed recognition 
of patients as having dermatomyositis. A skin biopsy showing 
typical changes of interface dermatitis was included as part of 
the selection criteria for subjects used in the criteria study, and 
it was recommended to utilize skin biopsies in addition to the 
clinical criteria to avoid inclusion of mimickers of DM. Interface 
dermatitis is a histopathological pattern of inflammatory skin 
disease with the dermoepidermal junction obscured by hy-
dropic degeneration and/or lichenoid cellular infiltrate. These 
new EULAR/ACR criteria allow classifying amyopathic DM in 
approximately 75% of patients. 
There is now an ongoing collaborative effort to further refine 
the skin variables, so that more CADM patients can be cor-
rectly classified as DM. A pre-delphi, followed by two rounds 
of Delphi have narrowed potential classification criteria from 
54 to 22 items that are now being tested prospectively in an in-
ternational collaboration including dermatologists and rheu-
matologists. The variables to be tested include morphology, 
distribution, symptoms, presence of myositis antibodies, and 
contextual factors such as interstitial lung disease (ILD) and 
muscle weakness. The goal is to develop and validate skin 
criteria for dermatomyositis so as to correctly classify as many 
patients as possible, with the target group being patients with 
amyopathic dermatomyositis.
Features of DM can be helpful in terms of determining risk 
of ILD, with mechanics hands seen somewhat more often in 
patients with ILD, although prevalent in those without ILD 
or anti-synthetase antibodies. It is clear that anti-synthetase 
antibodies can be seen in patients with skin features of DM, 
and thus defining DM with or without anti-synthetase antibod-
ies may help define distinct subsets. Many patients with DM 
or CADM and ILD do not have anti-synthetase antibodies, so 
there is a lot of overlap of systemic features. MDA-5 antibodies 
define a subset of patients who may have rapidly progressive 
ILD. MDA-5 patients have more lung disease, skin ulcers, pal-
mar papules, mechanics hands, oral lesions, and alopecia. Skin 
ulcers in DM can be due to vasculopathy, vasculitis, excessive 
inflammation at the interface between the dermis and epider-
mis, or due to excoriations in response to pruritus. Antibodies 
are beginning to help define phenotypes of disease. There is 
however, a need for better standardization of measurement of 
DM autoantibodies. A recent study showed just 14% of patients 
with dermatomyositis had myositis specific antibodies and 21% 
had myositis associated antibodies when testing was done in 
commercial labs. Hopefully the detection rate of autoantibod-
ies will improve with time and allow better correlation with 
disease phenotype. 
Therapies for DM have included topicals, sun protection, anti-
malarials, immunosuppressives, IVIG, and for refractory cases 
tacrolimus, IVIG, and JAK inhibitors. There is a need for inde-
pendent critical evaluation of skin manifestations of DM with 
reliable and validated measure of skin disease severity. There is 
now a validated disease severity tool, the CDASI, that is being 
used for clinical and translational studies in dermatomyositis 
where skin is an important outcome. There are a number of 
phase 2 trials that are examining potential new therapies for 
DM and looking at skin as a primary outcome that may improve-
ment treatment options for patients with DM.
In summary, clinical findings in the skin include both primary 
and secondary changes. The new EULAR/ACR criteria allow 
identifying 75% of patients with amyopathic DM. An ongoing 
prospective study will further refine criteria for the patients with 
skin predominant disease. Histology in about 80% of cases of 
dermatomyositis show interface dermatitis. There are some cas-
es that don’t show that pattern and that can make the diagnosis 
more difficult. The key is clinical and pathological correlation. 
Measurement of skin outcomes in trials and other studies is 
now possible with the CDASI. This is facilitating new trials that 
include skin outcomes for DM.
melaNoma malIgNUm — cURReNt State of dIagNoSIS aNd 
tReatmeNt
Rolland Gyulai
Department of Dermatology, Venerology and Oncodermatology, University 
of Pécs, Hungary
Recent advances in melanoma genetics and immunoregulation 
have led to fundamental changes in our understanding of mel-
anoma pathogenesis. These changes have also revolutionized 
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the therapeutic approach to patients with melanoma, resulting 
in new treatment paradigms and dramatically improved patient 
outcomes. Currently, the standard-ofcare for metastatic mela-
noma has evolved as either combination therapy with a BRAF 
and a MEK inhibitor or immunotherapy with a programmed 
cell-death protein 1 (PD1) immune checkpoint inhibitor. Tar-
geted and immunotherapy approaches are now also part of the 
adjuvant therapeutical landscape. State-of-the-art treatment 
of metastatic melanoma, however, requires proper clinical, 
pathological, genetic and radiological evaluation of the patient 
before and during the therapy. In this lecture, we review the 
current state of the field and outline a rational approach to the 
diagnosis and treatment selection for patients with melanoma.
mohS mIcRogRaPhIc SURgeRy IN a daIly, RoUtINe PRactIce
Andrzej Bieniek
Medical Center Bieniek, Wrocław, Poland
Mohs Micrographic Surgery (MMS) is a staged excision of skin 
tumors with complete and fast histopathologic examinations 
of surgical margins, enabling exact correlation of localization 
of pathologic structures identified in histologic picture and on 
body integument. It allows for complete and selective removal 
of neoplastic structures, thus assuring highest cure rates and 
possibility of conservation of healthy tissues. It is indicated in 
skin tumors developing through continuity.
In 1994 for the first time in Poland author with coworkers per-
formed operations with use of “3 D-Histology” of Breuninger 
(Slow Mohs, Paraffin Mohs). Still, this method in our hands 
proved to be too time consuming. In order to speed up the 
course of the treatment in 1999 we introduced first operations 
with use of MMS in frozen sections technique (fresh tissue). At 
the beginning we employed the most common technique of 
tissue mounting “direct method — float”. In spite of the great 
experience in “classical” histological technique our technicians 
were not skillful enough to produce correct MMS slides, lead-
ing frequently to: — sections taken deeply from the surface of 
tissue block (entering into the tumor), or — incomplete tissue 
sections (which did not comprise whole surgical margin). Be-
cause of difficulties and drawbacks of “direct method” many 
specialists developed their own techniques (author identified 
16 of them). Some are efficient enough for obtaining good 
sections (complete, from the very surface of the tissue block). 
Still, after changing the position of the cryostat chuck (socket), 
the manual adjustment is required, what causes loss of time, 
and loss of tissue (“entering” the tumor — false positive results). 
b-S laboratory device. That’s why I decided to design a de-
vice with a new function of adjustment of the tissue block to 
any position of cryostat chuck in cryostat. I began my work 
on new device in 2004, and in 2008 Eng. Szymkowski joined 
me. Beside the new function it allows for creation of precise 
tissue block, assuring improved precision and speed of tissue 
mounting and sectioning. Planar adjustment is carried out 
in 3 steps: Step I) Preparation of the “sample block without 
tissue. Step II) Sectioning of “sample block” in cryostat into 
sections (5-10 μm thick) and taking 3 measurements: 1. Point 
at which section begins, 2. Depth (from the block surface) 
an which section encompasses whole surface of the block, 
3. Diameter of the block, Step III) Regulation of handwheels 
with aid of an application “Block Alignment Calculator” (wor-
king in Android System and to be installed free from Google 
Play). The optimal alignment of the tissue block lasts usually 
2 minutes. The ability to align the surface of the block to the 
current cutting position of the cryostat knife — in cryostats 
with the adjustable “socket” allows to abandon its manual 
adjustment. In cryostats with a fixed “socket” — it allows to cor-
rect the small inaccuracies of their factory setting and adapt 
to the variable position of the knife. The B-S device allows for 
obtaining full sections from the top layers of the tissue block 
(sections from preparations with a diameter of 10-40 mm 
were obtained at a depth of 40-210 μm, on average 111.57 μm 
[median 110 μm, standard deviation (SD) 44.38 μm]). This 
reduces risk of the “false positive results” (and the number of 
unnecessary excisions) — what is extremally important when 
treating small structures (e.g. eyelids). It allows for creation 
of large sections (up to 4 cm), what reduces time of tissue 
processing and risk of “false positives”. Its operation is easy, 
tissue mounting proceeds in well-defined and easy-to-follow 
steps, what does not require extraordinary manual skills or 
long-lasting learning process.
Tumor mapping in MMS. The thorough graphical documen-
tation is necessary in MMS. Formerly it was made by hand dra-
wings: on blank paper, on ready — made schemes of different 
body areas, on foils attached to Polaroid photos, on print — outs 
of digital photos. Lately many authors introduced digital map-
ping systems in MMS (Papa, Lin, Alcalay, Nijssen). We employ 
own digital mapping system working in Windows®. The program 
is placed on the server with enabled access from the different 
participants of the treatment. By admission — surgeon intro-
duces the textual data and draws (on the skin) clinical margins 
of the tumor, preliminary margins of excision, marking points 
in the circumference, takes a digital photograph and introduces 
it to program. During surgery: surgeon draws digitally exact 
margins of excision and marking points of the circumference. In 
histo-laboratory: technician draws lines of division, introduces 
numbering and color coding. By histologic diagnosis: surgeon 
and /or pathologist introduces the results of diagnosis both of 
the biopsy (tumor) (in textual form) and excision margins (in 
textual and graphical form). After completing the histologi-
cal diagnosis the map is analyzed by surgeon, who in case of 
“positive margins” determines the area of necessary excision, 
performs it, draws its area onto the map, passes the case again 
to the technician, etc, in case of “negative margins” — closes the 
wound. The Digital Tumor Mapping is illustrating more precisely 
the tumor margins with its surroundings, cancer infiltrations, 
and extent of post-operative defect. During follow up visits it 
serves as easy to open source of information.
Telepathology in MMS. In many countries according to formal 
requirements, the engagement of a qualified pathologist in 
MMS is mandatory. Still, it’s usually not easy to obtain immedia-
te, repeated histopathological consultation “on demand”. That’ 
why many trials were undertaken on the use of “telepathology” 
in MMS. Professional systems are costly, have long scanning 
time (8-15 minutes) and produce “heavy” scans (up to 1 GB). 
Cheaper and simpler solutions may not be reliable enough to 
assure sufficient quality. We introduced manual telepathology 
system Microvisioneer®. Slides are analyzed by surgeon and 
scanned simultaneously (objective x4 — time 2-3 minutes, files 
100-400 MB). Then pathologist performs “remote” examination, 
and makes his (secondary) diagnosis. It proved to be a reliable 
and fast instrument of remote histological diagnosis.
Statistics in MMS. MMS is closely related to classical surgical 
excision (Excision with Predetermined Margins — EPM), but the 
methods vary in form and width of tumor removal. Determining 
of the exact relations between them is difficult. Therefore we 
attempted to introduce the index of radicality (completeness) of 
tumor removal (IRTR) as well as the index of extent of post-ope-
rative defects (IED). The indexes are derived from the following 
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data: 1) The widest margin of excision in MMS [Marg Max MMS], 
2) The mean margin of excision in MMS [Marg Mean MMS], 
3) The hypothetical margin of classical excision with prede-
termined margins [Marg EPM]. IRTR = (Marg Max MMS)/(Marg 
EPM), IED = (Marg Mean MMS)/(Marg EPM)
During 668 operations of BCC with use of MMS, the following 
results: were obtained:
IRTR — Index of radicality of tumor removal (33.3–444%, 
mean 106.20%) The excision by MMS was more radical [by 
mean of 6.2% — not significant statistically]. In (12.57%) (index va-
lue =100%) surgical excision and MMS would be equally complete 
and radical (effective). In (51.64%) [IRTR] (index value below 100%) 
surgical excision would be effective, but made with an excess of 
healthy tissue (too radical). In 237 cases (35.47%) (index value 
over 100%) — the surgical excision would leave residual tumor. 
IED — Index of extent of the defects (33.3–344.41%, mean 
84.93%). Defects after MMS were smaller (by mean of 15.07% 
— what was statistically significant). In (11.52%) (index value = 100%) 
— both methods would create similar defects, in (71.10%) — (index 
value below 100%) — defect after MMS were smaller, in (17.36%) 
— (index value above 100%) — defects after MMS were bigger. 
Our modifications may play a role in the everyday practice of 
MMS. In 1997 the first Polish Conference on Mohs Surgery was 
organized by the Department of Dermatology, Medical Univer-
sity of Wrocław. In 2017 the idea of the Courses was resumed 
by Centrum Medyczne Bieniek.
NeW tReNdS IN the tReatmeNt of atoPIc deRmatItIS
Jacek Szepietowski 
Department of Dermatology, Venereology and Allergology, Wrocław Medical 
University, Poland
Abstract was not submitted.
moRPhea aNd Related dISoRdeRS: the PaSt aNd the 
fUtURe 
Aleksandra Dańczak-Pazdrowska 
Noninvasive Diagnostic of Skin Diseases Unit at Department of Dermatology, 
Poznań University of Medical Sciences, Poland
Morphea, also known as localized scleroderma, is an immune-
-mediated, fibrosing skin disorder which belongs to autoimmu-
ne connective tissue group of diseases and affects both children 
and adults. There is huge variation in the clinical presentation 
of morphea. The course of disease is chronic and unpredictable. 
It may cause tissue atrophy, dyspigmentation, but also con-
tractures or even functional disability. There is no one, unique, 
generally accepted classification system. The mode of treatment 
depends on severity of the disease. The mildest forms can be 
treated topically, in more severe cases methotrexate (with or 
without systemic glucocorticosteroids), or phototherapy are 
usually recommended. However, the treatment of severe forms 
of morphea may be challenging. There are variety of disorders 
and diseases which belong to so called scleroderma spectrum 
disorders (term used to describing a spectrum of conditions 
characterized by hardening and/or thickening of the skin and 
adjacent tissues), which should be considered in differential 
diagnosis. The aim of this presentation is to summarize and 
to synthesize the information into a rational approach to the 
diagnosis and management of patients with morphea.
PSoRIaSIS UPdate
Paul Sator 
Department of Dermatology, Hietzing Hospital, Vienna, Austria
Psoriasis is a chronic inflammatory disease with underlying 
autoinflammatory pathomechanisms. A recent systematic re-
view of the worldwide literature regarding epidemiology of 
psoriasis estimated that the prevalence in adults ranges from 
0.51% to 11.43%.
Several comorbidities are associated with psoriasis, including 
psoriatic arthritis and cardiometabolic disorders. In addition to 
its clinical burden, psoriasis also has significant psychosocial 
impact. In large surveys of patients with psoriasis, respondents 
have reported that psoriasis can affect emotional state, interfere 
with daily life, and have a negative impact on work, relationships 
and sleep quality and quantity. Additional factors, including 
involvement of highly visible or bothersome areas (e.g. scalp, 
nails, genitals, palms and/or soles) or symptoms (e.g. itching) 
significantly impair QoL and impact patient-perceived severity.
About 50% of patients treated by dermatologists have mo-
derate-to-severe psoriasis, which, according to S3 guidelines, 
requires systemic treatment. Parameters used in daily practice 
to classify psoriasis as mild, moderate or severe are the Psoria-
sis Area and Severity Index (PASI), Dermatology Life Quality 
Index (DLQI) and Body Surface Area (BSA). Moderate-to-severe 
psoriasis is defined by a European consensus as (BSA>10% or 
PASI>10) and DLQI>10.
Currently, available treatments for moderate-to-severe psoriasis 
include phototherapy, small molecules and biologics. Biologic 
drugs, such as anti-tumor necrosis factor and specific monoclonal 
antibodies (IL-12/23, IL-17, IL-23), revolutionized treatment para-
digms in psoriasis. More and more patients achieve a PASI 100 due 
to these potent therapies. Hence, non-invasive biomarkers are 
sought to predict treatment outcomes and individualize care for 
patients with psoriasis. Even as treatment of psoriasis becomes 
safer, it is important to recognize both common and uncommon 
adverse effects of treatment. Common adverse effects are similar 
across treatment options, including upper respiratory infection 
and injection-site reaction. Serious adverse effects occur less 
frequently and specific to the psoriasis treatment option, such 
as inflammatory bowel disease and candida infections with IL-
17 inhibitors or tuberculosis with certolizumab pegol.
Data from registries provide important information of biological 
treatments on a high efficacy and long-term safety. Due to the 
approval of biosimilars the biological therapies are also more 
and more cost-effective.
The introduction of biologics may greatly improve patient 
outcomes.
maNy ShadeS of PSoRIaSIS
Joanna Narbutt 
Department of Dermatology, Pediatric Dermatology and Oncology, Medical 
University of Łódź, Poland
Psoriasis is an immune-mediated, genetic disease manifesting 
in the skin or joints or both. Due to involvement of many or-
gans, a diverse team of clinicians is often needed to treat the 
disease. Psoriasis provides many challenges including high 
prevalence, chronicity, disfiguration, disability, and associated 
comorbidity. When the role of immune function in psoriasis and 
the interplay between the innate and adaptive immune system 
had been discovered, new therapeutic options have been de-
veloped. During the lecture I will highlight the clinical diversity 
of psoriasis and associated comorbid diseases. I would like to 
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raise awareness of the complexity of this multifaceted disease, 
the potential of state-of-the-art therapeutic approaches, and 
the need for early diagnosis and comprehensive management 
of patients with psoriasis.
NeW PeRSPectIveS IN SkIN caRcINogeNeSIS
Aleksandra Lesiak
Department of Dermatology, Pediatric and Oncological Dermatology and 
is a coordinator of Dermatology for Children of Medical University of Łódź, 
Poland
Discovered in 2002, cytoplasmic multi-protein complexes, 
called inflammasomes, are key regulators of the innate immune 
response, activated under the influence of various endo- and 
exogenous stressors. One of the permanent external stressors 
that significantly affects the homeostasis of the body is ultra-
violet radiation (UVR), which, as recent research has shown, 
can be an inflammasome activating factor. Until now, the 
best-characterized inflammasomes are NLRP1(NOD-Like Re-
ceptor Family Pyrin Domain Containing 1) and NLRP3 (NOD-
Like Receptor Family Pyrin Domain Containing 3). Until now, it 
is known that UVR can affect the function and structure of the 
NLRP1 and NLRP3 inflammasomes, but the exact molecular 
mechanisms underlying this phenomenon have not been suf-
ficiently described. In the context of the growing incidence of 
non-melanoma skin cancers (NMSC), where the main risk factor 
is chronic exposure to UVR, it becomes necessary to determine 
how inflammasomes regulate the process of their formation and 
development. Thus, the aim of the current presentation is to 
describe the potential role of NLRP1 and NLRP3 inflammasomes 
in skin carcinogenesis 
PaRaNeoPlaStIc SyNdRomeS IN deRmatology
Beata Bergler-Czop 
Chair and Clinic of Dermatology, Silesian Medical University, Katowice, Poland
A variety of cutaneous abnormalities can be seen in patients 
with malignant diseases, some of which are infectious, with 
others representing direct involvement of the skin by the 
underlying disorder. Yet another group of lesions can be re-
garded as associated markers of the malignant process, and, 
as such, are termed “paraneoplastic”. This review considers the 
latter collection of conditions, grouping them by the generic 
type of malignancy that is usually linked to the paraneoplasia. 
Some of the processes show a predominant association with 
alimentary tract malignancies (acanthosis nigricans, acro-
dermatitis paraneoplastica, florid cutaneous papillomatosis, 
necrolytic migratory erythema, palmoplantar keratoderma, 
pancreatic fat necrosis, and pityriasisrotunda). Others are 
usually linked to a hematolymphoid malignancy (acquired 
ichthyosis, exfoliative erythroderma, necrobiotic xanthogranu-
loma, pemphigus paraneoplastica, plane xanthoma, pyoder-
ma gangrenosum, scleromyxedema, Sweet syndrome, and 
leukocytoclastic vasculitis). Finally, yet another collection of 
paraneoplastic skin disorders can associate themselves with 
anatomically-diverse malignancies (Leser–Trelat syndrome, 
Trousseau syndrome, dermatomyositis, erythema gyratum 
repens, hypertrichosis lanuginosa acquisita, papuloerythro-
derma of Ofuji, tripe palms, and multicentric reticulohistio-
cytosis). Recognition of these processes by the pathologist 
can be a valuable step in the characterization of underlying 
malignant diseases.
NoN StI deRmatoSeS IN aNogeNItal aRea
Adriana Polańska 
Department of Dermatology and Venereology Poznań University of Medical 
Sciences, Poland
Anogenital area due to the specific conditions (e.g. humidity, 
rubbing of adjacent surfaces) and exposition to various irritants 
and allergens, is the common specific cutaneous localization 
of non-sexually transmitted dermatoses including inflamma-
tory and infectious one. This particular localization makes the 
presentation of the lesions much different than within the 
glabrous skin. The involving of genitalia, especially in young 
male patients, can stigmatize them due to the attribution of 
the venereal origin. However, sexually transmitted infections 
(STI) constitutes only minority of the lesions located within that 
area. More common are lichen simplex, psoriasis or contact 
dermatitis. It should be also emphasized that involvement of 
anogenital area highly impairs the patients quality of life.
The aim of the lecture is to present the updated knowledge on 
non STI dermatoses of anogenital area, with special emphasis 
on inflammatory diseases like lichen simplex, lichen planus, 
contact dermatitis as well as lichen sclerosus. In differential 
diagnosis psoriasis, intertrigo and balanitis as well as infectious 
diseases will be discussed.
chRoNIc PRURItUS: dISeaSe of ItSelf
Adam Reich 
Department of Dermatology, University of Rzeszów, Poland
Itching is defined as an unpleasant sensation that causes a desi-
re to scratch. Itching is the most common subjective symptom 
of skin diseases, but it can also be present in many systemic, 
neurological or psychiatric diseases. According to the classi-
fication by the International Forum for the Study of Itch (IFSI), 
itching can be treated as acute (lasting less than 6 weeks) or 
chronic (lasting > 6 weeks). While short-term itching is often 
a defense mechanism that protects us from ectoparasites, 
chronic itching is a pathological phenomenon, which causes 
significant suffering to patients and reduces their quality of 
life. 
Contemporary classification of pruritus is also largely based 
on the clinical presentation of the skin in which the patient 
reports the occurrence of pruritus. According to the IFSI classi-
fication, patients are grouped into 3 subgroups: group I — pru-
ritus on lesional skin, group II — pruritus on unchanged, 
normally-looking skin, and group III — pruritus with secondary 
scratch lesions. The patient should then be classified into 
one of the categories of pruritus depending on its etiology: 
pruritus associated with skin diseases, pruritus associated 
with systemic diseases, neurological pruritus, psychogenic 
pruritus, or mixed pruritus. However, it is not uncommon, 
that the exact etiology cannot be defined and such cases are 
classified as pruritus of unknown etiology. Recently, many 
expert also suggested, that chronic pruritus can be considered 
as a disease on its own. 
QUo vadIS tReatmeNt of hIdRadeNItIS SUPPURatIva?
Łukasz Matusiak 
Department of Dermatology, Venereology and Allergology, Wrocław Medical 
University, Poland
Abstract was not submitted.
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INtRodUctIoN to the ReflectaNce coNfocal mIcRoScoPy 
Joanna Łudzik
Department of Bioinformatics and Telemedicine Jagiellonian University 
Medical College, Kraków, Poland
Skin tumors are the most frequent type of cancer in the ge-
neral population with epidemiological data showing a rising 
trend. Genetic and environmental risk factors play a crucial 
role in skin cancer development and include caucasian race, 
light colored skin, the number and type of naevi and a positive 
family history in the case of both BCC and MM. Sun burns and 
ultraviolet exposure are known environmental risk factors for 
skin cancers and it is believed that intense but intermittent 
sun exposure, especially on skin areas that are not usually sun-
-exposed, and a history of sunburns, especially in childhood and 
adolescence, play an important role in melanoma development. 
In recent years several non-invasive imaging modalities have 
emerged aimed at increasing accuracy of in-vivo diagnosis, of 
which reflectance confocal microscopy (RCM) has shown to be 
the most promising and popular amongst clinicians in Europe. 
RCM permits non-invasive (in-vivo) examination of the skin at 
cellular resolution from the surface down to the upper dermis 
enabling visualization of the relevant skin layers for skin tumor 
evaluation and diagnostic confirmation by enabling the visu-
alization of tissue in its physiological state avoiding retraction 
bias due to fixation, staining and sectioning procedures that are 
a prerequisite of conventional light histopathology. Additionally, 
RCM permits cellular level observation of changes over time. The 
application of this technology is quite advantageous in the scre-
ening of malignant skin tumors as well as inflammatory diseases, 
monitoring of pigmentary skin disorders and cosmetology. The 
first description of RCM for the imaging of human skin in-vivo 
was in 1995 by Rajadhyaksha and colleagues and morphology 
of naevi and melanoma were first described in in 2001 as well 
as the potential for this technique to aid in detecting clinically 
amelanotic melanoma. The integration of digital dermoscopy 
imaging with the reflectance confocal microscope was proposed 
by Prof. Giovanni Pellacani in 2004 during his research in Mo-
dena, Italy which highlighted the ability of RCM to be a bridge 
between clinical naked-eye with dermoscopy examination and 
histopathology and was the foundation upon which RCM tech-
nology is designed and implemented today in clinical practice.
hoW to INteRPRet hIStoPathologIcal RePoRtS?
Joanna Czuwara 
Department of Dermatology, Medical University of Warsaw, Poland
The interpretation of the skin biopsy is very important for 
the dermatological diagnosis. There are neoplastic and in-
flammatory dermatoses in which histopathological findings 
are characteristic or pathognomonic making the final dia-
gnosis with certainty. There is also a group of diseases in 
which clinical-pathological correlation, location or clinical 
anamnesis determinate the most likely diagnosis. Also histo-
pathological differential diagnosis is different than clinical 
one, and the interpretation may relay on the anatomic site 
and clinician experience. Another histological aspect is so 
called “life of lesion” in which time duration or secondary 
changes such as scratching or bacterial infection influence 
the epidermal and dermal events and dermatopathologist 
has to refer to the most basic event which has triggered the 
chain of changes for establishing the most probable entity 
underneath the overlying changes. 
Very important point for the interpretation of histopathology 
is description of epidermal changes (spongiosis in ecze-
ma, exocytosis in many inflammatory diseases, acanthosis, 
acantholysis in different types of pemphigus and HSV/VZV 
infection, type of parakeratosis, dyskeratosis and interface 
changes) because they differentiate type of dermatoses 
(drug and infection induced, autoimmune, psoriasiform, 
cytotoxic, lichenoid and types of cutaneous lupus erythe-
matosus among others. The composite of inflammatory 
infiltrate is also crucial for diseases distinction e.g. allergic, 
neoplastic, neutrophilic, vascular and dermal including the 
arrangement of skin infiltration such as perivascular, nodular, 
follicular or diffuse. 
Helping mnemonic such 8Ls was created for differentiation of 
superficial and deep inflammatory cell infiltrate in the dermis 
to better remember the following light reactions, lymphoma, 
leprosy, lues, lichen striatus, lupus erythematosus, lipodidica 
and lepidoptera or DRUGS for dermatophyte, REM, urticarial 
diseases, gyrate erythemas, scleroderma and drug reactions. 
Undoubtedly the interpretation of the skin biopsy is a ma-
instay diagnostic tool for many, if not all dermatological 
entities. It should be remembered that proper description of 
the skin lesion, not only clinical suggestion and location of 
the biopsy site strongly influence the quality of pathological 
report, but the first condition is the depth and size of the 
biopsy which purely depends on the clinician. 
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Abstracts of young dermatologists
gRaNUloma facIale IN a 59-yeaR-old maN
Anna Ryczek, Ewa Żabska 
Department of Dermatology, University of Rzeszów, Poland 
A 59-year-old man was admitted to the Dermatology Depart-
ment in Rzeszów presenting with a 6-years history of the slowly 
growing tumor on the scalp. The skin lesion developed after 
a minor trauma. In the past the patient had been also exposed to 
ultraviolet radiation for several years as he worked at the outdoor 
construction site. Physical examination on admission revealed 
an erythematous tumor (diameter of 6 cm) with visible telean-
giectasias. Histopathological examination showed Grenz zone, 
and the infiltration of neutrophils, lymphocytes and eosinophils 
in the deeper dermis. Based on the clinical manifestation, medical 
history and histology, facial granuloma (GF) was diagnosed. GF is 
a rare, benign, inflammatory skin disease, usually isolated. It usu-
ally occurs on the forehead, nose or cheeks. GF is most commonly 
seen in middle-aged Caucasian males. The treatment is difficult 
and includes: topical corticosteroids, tacrolimus, cryotherapy, 
dapson, hydroxychloroquine, colchicine, phototherapy and lasers.
SchNItzleR SyNdRome
Klaudia Tutka, Adam Reich
Department of Dermatology, University of Rzeszów, Poland
introduction: Schnitzler syndrome belongs to the group of 
auto-inflammatory diseases. This disorder is characterized by 
a chronic urticarial rash and monoclonal IgM or less frequently 
IgG gammopathy. It is a rare disease with about 300 cases de-
scribed in the literature. Schnitzler syndrome may be associated 
with malignancy, as lymphoproliferative disorders develop in 
about 20% of patients
case report: Here, a 67-year-old woman with chronic urticarial rash 
is demonstrated. The patient also manifested general symptoms 
such as recurrent fever, abdominal pain, arthralgia and paresthesia. 
The diagnosis of Schnitzler symptom was established based on the 
clinical picture, abnormal laboratory tests and histopathological 
examination of the skin lesions. Systemic glucocorticosteroids 
were started with a very good therapeutic effect.
conclusions: The presented case underline a major diagnostic 
challenge of Schnitzler syndrome due to its rare occurrence. The 
proper diagnosis is essential for the identification and treatment 
of comorbidities, which may worsen the prognosis.
excISIoN bIoPSy foR SUbUNgUal melaNoma
Aleksandra Opalińska, Dominik Samotij, Adam Reich
Department of Dermatology, University of Rzeszów, Poland
A 55-year-old woman was admitted to the Dermatology De-
partment in Rzeszów because of pigmented lesion within the 
nail plate of the 4th digit of the left hand. Physical examination 
and then dermoscopic view of the pigmented lesion revealed 
multicolored, slightly trapezoidal lesion involving almost 50% of 
nail plate, and slight dystrophy of the distal edge of the nail plate. 
Although the longitudinal melanonychia persisted for 2.5 years, 
the patient did not visit any physicians before. Considering the 
anamnesis and clinical manifestation, the excisional biopsy of 
the pigmented lesion of nail matrix was performed. Based on 
the histopathological examination malignant melanoma in situ 
was diagnosed.
PhototoxIc ReactIoN afteR coNtact WIth PoISoN Ivy — 
a caSe RePoRt
Ewelina Kosior
Department of Dermatology, University of Rzeszów, Poland
A 75-year-old man was admitted to the dermatology depart-
ment with generalized erythemas and hives. The first skin 
lesions appeared one week before hospitalization, and their 
appearance was preceded by gardening in the USA. Based on 
the medical history it was revealed that poison ivy grew there-
abouts. The rash improved with parenteral and topical steroids 
and antihistamine treatment. Poison ivy is the most common 
cause of allergic contact dermatitis in the USA. In Europe, as 
opposed to North America, poison-ivy rash is hardly known. 
Intense pruritus and redness develop soon after the skin is 
exposed to urushiol, which is found in the resin of poison ivy. 
Vesicles typically occur 12–48 h after exposure. The treatment 
for poison ivy dermatitis varies depending on the severity of 
the reaction and includes antihistamines and steroids.
ScleRodeRma oveRlaP SyNdRome
Kamila Jaworecka, Adam Reich, Dominik Samotij
Department of Dermatology, University of Rzeszów, Poland
Systemic sclerosis is an autoimmune connective tissue disease 
(CTD) characterized by progressive fibrosis of the skin and inter-
nal organs, injury of blood vessels and the presence of autoan-
tibodies. The diagnosis of systemic sclerosis may sometimes be 
challenging, especially in the early stage of the disease. Some 
patients may also demonstrate features of more than one auto-
immune CTD suffering from so called overlap syndromes. Here, 
we present a case of a 20-year-old man, with digital ulcers and 
interstitial lung disease (ILD), however, without any skin hard-
ening. The laboratory examination revealed the presence of 
anti-PM/Scl antibodies. As the patient did not fulfil diagnostic 
criteria of any specific CTD, an overlap syndrome has been 
diagnosed. Due to progressing ILD and digital ulcers the treat-
ment with intravenous cyclophosphamide combined with oral 
sildenafil was administered, which resulted in complete healing 
of the skin lesions and stabilization of ILD.
cUtaNeoUS collageNoUS vaScUloPathy: a RePoRt of tWo 
caSeS
Marcelina Pojawa-Gołąb, Justyna Szczęch, Dominik Samotij, Adam Reich
Department of Dermatology, University of Rzeszów, Poland
Cutaneous collagenous vasculopathy is a rare idiopathic mi-
croangiopathy clinically manifesting with acquired cutane-
ous telangiectasias. Here, we report two cases occurring in 
a 33-year-old woman and a 66-year-old man who both pre-
sented with disseminated telangiectasias and no additional 
symptoms accompanying the abnormal cutaneous findings. In 
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both patients, the diagnosis was confirmed by skin biopsy that 
showed dilated superficial cutaneous vessels with marked colla-
gen deposition within the vessel walls. Cutaneous collagenous 
vasculopathy is considered a rare yet underrecognized and 
underreported cause of generalized teleangiectasias. Typically, 
skin lesions spread progressively from distal parts of the lower 
limbs towards the trunk and upper extremities. Face is usually 
spared, as well as mucous membranes. Histological examination 
of skin biopsy specimen shows the presence of a thick hyaline 
collagenous wall around the affected capillaries, comprising 
the accumulation of collagen type IV. Differential diagnosis 
includes mainly generalized essential telangiectasia which dis-
plays identical clinical presentation.
NeoNatal lUPUS eRythematoSUS — a caSe SeRIeS  
of 3 PatIeNtS
Beata Polkowska-Pruszyńska, Karolina Sawicka, Bartłomiej Wawrzycki, 
Joanna Pucuła, Anna Michalak-Stoma, Małgorzata Michalska-Jakubus, 
Dorota Krasowska
Chair and Department of Dermatology, Venerology and Paediatric 
Dermatology, Medical University of Lublin, Poland
Neonatal lupus erythematosus (NLE) is a rare autoimmune 
disease associated with maternal anti-Ro/La or anti-U1-RNP 
antibodies transmission. Spontaneously resolving cutaneous 
lesions usually appear a few weeks after birth, commonly af-
fecting face and scalp. The most serious NLE manifestation is 
third-degree heart block.
We present a case series of 3 infants, who developed annular, 
erythematous plaques with central clearing during 4th to 7th 
week of life and were diagnosed with NLE. Additionally, patients 
suffered from thrombocytopenia, transaminase elevation and 
right bundle branch block. Laboratory findings revealed the 
presence of antinuclear antibodies in mothers, who were di-
agnosed with Sjögren’s syndrome.
NLE may be the first sign of the connective tissue disease in hith-
erto asymptomatic mothers, as described in our case series. NLE 
suspicion should indicate a need of careful diagnostics both in 
children and mothers, due to possible perinatal complications.
PemPhIgUS vegetaNS PoSSIble aSSocIatIoN WIth eNalaPRIl
Paulina Barasińska
Department of Dermatology, Pediatric Dermatology and Oncology Clinic, 
Władysław Biegański Hospital in Łódź, Poland
Pemphigus vegetans is the least common form of pemphigus, 
clinically manifested by blisters transforming into papillous 
or pustular eruptions. Treatment involves administration of 
systemic glucocorticosteroids in monotherapy or combined 
with immunosuppressants.
A 58-year-old man was admitted with papillous lesions persisting 
for few weeks in the anogenital area and axillae, receiving hypo-
tensive enalapril for several months, diagnosed with pemphigus 
vegetans based on clinical manifestation and immunopathologic 
examination. Enalapril was discontinued and prednisone was intro-
duced at the maximum dose of 2 mg/kg/day, with subsequent im-
provement of the condition. Considering adverse effects of chronic 
glucocorticosteroid therapy, azathioprin was also introduced at 
the dose of 50 mg/day, with gradual reduction of the prednisone 
dose. The patient in good condition remains under dermatological 
supervision.
A case report presents a patient with lesions initially suggesting 
papillary pyroderma, which subsequently underwent rapid 
progression, significantly hindering the daily functioning of 
the patient, and which may have been induced by enalapril.
lIcheN PlaNUS atRoPhIcUS aloNg lINeS of blaSchko — 
caSe RePoRt
Paulina Cieplewicz1, Aleksandra Dańczak-Pazdrowska1,  
Monika Bowszyc-Dmochowska1, Ryszard Żaba2, Zygmunt Adamski1, 
Adriana Polańska2
1 Department and Clinic of Dermatology, Poznań University of Medical 
Sciences, Poland
2 Department of Dermatology and Venerology, Poznań University of Medical 
Sciences, Poland
Lichen planus is an inflammatory, non-infectious dermatosis 
characterized by presence of itchy papules in predilections 
sites as: the inner part of the wrists and the back of the feet. 
The lesions often occur in mucous membranes. Nail dystrophy 
and fibrosing alopecia are less common presentations of that 
disease. There are clinical variants of this dermatosis that have 
been described so far including lichen planus atrophicus. We 
present a rare variant of lichen planus atrophicus along the lines 
of Blaschko and the difficulties associated with its treatment.
INtoxIcatIoN of methotRexat — challeNgINg PatIeNt
Aleksandra Jonkisz, Bartłomiej Wawrzycki, Joanna Bartosińska,  
Dorota Krasowska
Chair and Department of Dermatology, Venereology and Pediatric 
Dermatology, Medical University of Lublin, Poland
The poisoning of the MTX is most often caused by patients’ 
overdosing the drug by mistake or physicians’ incorrect rec-
ommendation. The MTX intoxication leads to the bone marrow 
suppression and the dysfunction of the liver and kidney as it 
impairs the process of cells’ proliferation.
The aim of this study is to present three cases of patients who 
developed the symptoms of MTX toxicity. Patients were admit-
ted to the hospital because of extensive erosions developed on 
the mucous membrane of the mouth and throat.
Levofolinic acid, filgrastim and preparations supporting kidney 
and liver function were used in the treatment, resulting in the 
disappearance of skin and mucous lesions and improvement of 
laboratory parameters. Skin and mucosal lesions may precede oth-
er complications associated with MTX intoxication including bone 
marrow suppression. The prognosis depends on the adopted MTX 
total dose and the time of the intensive treatment implementation
StoRIeS of a RaRe bUt SPectacUlaR dISeaSe WIth SkIN 
leSIoNS
Julia Seniuta1, 2, Leszek Szenborn2, Zofia Szymańska-Toczek2,  
Katarzyna Tkaczyszyn2 
1 Clinic of Dermatology, Venerology and Allergology, Wrocław University 
Hospital, Poland
2 Clinic of Pediatric Infectious Diseases, Wrocław University Hospital, Poland 
TRAPS is a genetically determined syndrome in which relapsing 
fever episodes are accompanied by skin symptoms.
I.  A 9-month-old boy was admitted to the clinic due to the third 
episode of high fever and non-characteristic skin lesions. The 
analysis of the interview suggested the auto-inflammatory 
nature of the disease, which was confirmed by genetic testing.
II.  A 23-month-old boy was admitted to the clinic because of 
relapsing fevers of unknown origin. From early childhood, 
the child has been repeatedly hospitalized with the diag-
nosis of erythema multiforme, erythema annular or allergic 
rashes. The periodic occurrence of fever episodes suggested 
an auto-inflammatory basis of changes, which was confirmed 
by the detection of mutations in the TNFRSF1A gene.
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The occurrence of periodic episodes of fever with skin changes 
and laboratory markers of intensified inflammation, should be 
differentiated with autoinflammatory diseases, which is an in-
dication for genetic testing, including TRAPS.
the ReactIvatIoN of heRPeS SImPlex vIRUS INfectIoN aS 
a ReSUlt of PhotodyNamIc theRaPy — caSe RePoRt 
Marta Szymoniak-Lipska1, Aleksandra Dańczak-Pazdrowska1,  
Ryszard Żaba2, Zygmunt Adamski1, Adriana Polańska2
1 Department and Clinic of Dermatology, Poznań University of Medical Sciences , Poland
2 Department of Dermatology and Venerology, Poznań University of Medical 
Sciences, Poland
Actinic keratosis (AK) is a common disorder, presented with 
scaly, erythematous lesions. It is associated with chronic expo-
sure to ultraviolet (UV) radiation. AK is capable of transforming 
into an invasive squamous cell carcinoma.
Photodynamic therapy (PDT) is one of non-invasive methods 
of treatment AK. PDT can either stimulate or repress immune 
response. Common early side effects occure directly after PDT 
and comprise erythema, eodema, desquamation or pustulae.
We report the case of a 61-year-old female patient who de-
veloped a reactivation of herpes simplex virus (HSV) infection 
localized to the nose, where PDT for AK had been performed. 
The patient received systemic antiviral therapy, and after treat-
ment the lesions had completely disappeared. Considering the 
broad use of PDT, the reactivation of HSV infection seems to 
be a very rare but potentially serious complication. It has to be 
distinguished from common inflammatory reactions after PDT.
ReactIve gRaNUlomatoUS deRmatItIS IN clINIcal 
PRactIce — 5 StUdy of tWo caSeS
Barbara Olszewska1, Adriana Polańska2, Monika Bowszyc-Dmochowska1, 
Ryszard Żaba2, Zygmunt Adamski1, Aleksandra Dańczak-Pazdrowska1 
1 Department and Clinic of Dermatology, Poznań University of Medical Sciences, Poland 
2 Department of Dermatology and Venerology, Poznań University of Medical 
Sciences, Poland
Reactive granulomatous dermatitis (RGD) is a rare dermato-
logical entity of unknown etiology, belonging to a group of 
non-infectious cutaneous granulomas that may mimic various 
connective tissue diseases and therefore requires a thorough 
approach from the dermatologist. Classic clinical manifestation 
of the disease described in the literature is that of asymptom-
atic red or violaceous well demarcated plaques with linear, 
cord-like distribution on the trunk and limbs in patients with 
arthralgia. However, more recent reports in the literature sug-
gests that clinical picture of the disease is more variable and 
may include multiple symmetrically distributed plaques and 
papules, urticarial plaques, erythematous nodules and annular 
lesions. Because of wide clinical spectrum, a diagnosis requires 
histological examination. We present two cases of RGD man-
ifested clinically with multiple, hard, subcutaneous nodules 
distributed symmetrically within the skin overlying joints.
dySPNea aNd aRthRalgIa IN a PatIeNt tReated foR 
hyPocomPlemeNtemIc URtIcaRIal vaScUlItIS SyNdRome
Paulina Sztefko
Department of Dermatology, Venereology and Allergology, Wrocław 
University Hospital, Poland
Hypocomplementemic urticarial vasculitis syndrome (HUVS) is 
a disorder characterized by urticarial lesions on the skin. Lab-
oratory findings include low complement levels and presence 
of anti-C1q antibodies in the serum. Although HUVS is mainly 
related with a skin manifestation, it can be also accompanied 
by extracutaneous manifestations such as laryngeal edema, 
arthritis, glomerulonephritis, and pulmonary involvment. Cor-
ticosteroids and immunosuppressive agents are usually used 
in the treatment.
This case shows a 52-year-old woman treated for the cu-
taneous manifestation of hypocomplementemic urticarial 
vasculitis syndrome from 3 years and reported artralgia and 
dyspnoea. There was no skin leasions in this patient from 
2016 due to treatment with methylprednisolone and dapson. 
An involvment of lungs and joints in the course of HUVS was 
suspected. Diagnostics revealed chronic obstructive pulmo-
nary disease more related with nicotinism and osteoarthri-
tis. Finally there was no treatment modification for HUVS. 
Inhaled corticosteroids and nonsteroidal anti-inflammatory 
drugs were administered for this patient.
xaNtogRaNUloma NecRobIotIcUm
Agnieszka Bożek, Adam Reich
Frederic Chopin Clinical Hospital in Rzeszów, Poland
Xantogranuloma necrobioticum is an extremely rare disease 
of unknown etiology, which is almost always accompanied 
by paraproteinemia. It is more common in older people. Char-
acteristic symptoms of the disease are red-yellow infiltrative 
plaques located typically in the orbital area, as well asthe rest 
of the face, neck and chest. Advanced changes can spread to 
the subcutaneous tissue and cause ulcerations. The histolog-
ical image shows massive necrobiosis, numerous giant cells 
and accumulation of lymphocytes. The case of a 51-year-old 
woman with xantogranuloma necrobioticum diagnosed on 
the basis of the clinical features and histological examination 
is presented. Skin changes were accompanied by IgG lambda 
monoclonal gammopathy. A magnitude of therapies were em-
ployed including chlorambucil, intravenous immunoglobulins, 
systemic and intralesional corticosteroids, cyclophosphamide 
and thalidomide, however, progression of skin lesions was 
observed despite treatment.
PUStUlaR RaSh WIth UNexPected develoPmeNt
Jan Hugo
Department of Dermatovenereology, 3rd Faculty of Medicine, Charles 
University, Prague, Czech Republic 
University hospital Královské Vinohrady, Prague, Czech Republic
A 44-year-old woman came to a outpatient night shift with pu-
stular rash lasting 1 day and fear of a chickenpox. She suffered 
from ankylosing spondyloarthritis, but she negated systemic 
medication. She was reassured that chickenpox is implausible, 
received topical therapy and was sent home. Four days later 
she came back because of a worsening. She reported new sore 
throat, CRP was 30, the condition was assessed as susp. para-
infectious exanthema/reaction due to viral pharyngitis. Next 
week, the skin condition worsened further, with new facial in-
volvement. A biopsy was performed with result “Acute purulent 
folliculitis and perifolliculitis with large amount of eosinophils”. 
The pathologist suggested a drug rash. At next follow-up, 
she had completely new scaling leasions and it was found 
that she had forgotten to mention experimental therapy with 
certolizumab-pegol for uveitis. Paradoxical psoriasis induced 
by TNF inhibitor has been suspected, with confirmation by 
a new biopsy.
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dRUg-INdUced SUbcUtaNeoUS lUPUS eRythematoSUS 
Justyna Szczęch, Dominik Samotij, Adam Reich 
Department of Dermatology, University of Rzeszów, Poland 
An 81-year-old woman, treated for six months dermatologically, 
was referred to the Department of Dermatology, Venereology 
and Allergology in Wroclaw due to the lack of a satisfactory 
therapeutic effect of previously used topical therapy with po-
tent glucocorticoid. On admission a numerous erythematous 
lesions with a characteristic ring-like structure were observed. 
They were localized on the skin exposed to UV radiation. The 
most severe skin lesions were present on the face, V-neck area 
and on the upper back. In addition, the patient complained of 
pruritus accompanying the skin lesions. The pruritus severity 
according to the 10-point NRS scale (Numerical Rating Scale) 
was 6 points. The patient emphasized that exposure to UV-
-radiation causes a significant exacerbation of skin lesions. The 
patient also complained about the excessive hair loss since 
3 months. Because of hypertension the patient has been treated 
for a year with spironolactone, and for more than two years in 
the treatment of gastroesophageal reflux disease she was taking 
a pantoprazole- a proton pump inhibitors (PPI). After cessation 
of PPI a gradual improvement of the skin lesions was observed. 
Patient was diagnosed with drug-induced subcutaneous lupus 
erythematosus.  
a leUkemIa INfIltRate of the NoSe SkIN
Edyta Sawińska, Adam Reich
Dermatology Clinic in Rzeszów, Poland
Multiform, nonspecific skin lesions, often occurring with pruritus, 
especially in the elderly, should always be differentiated with 
leukemia or lymphomas. 
Here, we present a case of 63-year-old woman, suffering from 
chronic lymphocytic leukemia, who was admitted to the Derma-
tology Clinic in Rzeszów because of the swelling and erythema 
within the nose. The first skin changes appeared about 7 days 
before hospitalization as a reddening and a gradually growing 
swelling of the top of the nose and nasal wings. Prior hospitali-
zation treatment with amoxicillin with clavulanic acid was used, 
however, no improvement was observed. On admission, a swel-
ling and an tender erythema of the top and wings of the nose 
with erosions was noticed. Lab tests showed leukocytosis with 
neutropenia and lymphocytosis and slightly increased –reactive 
protein level. Erysipelas of the nose area was suspected and the-
rapy with clindamycin subsequently combined with cefuroxime, 
but again, no improvement was achieved. Finally, a skin biopsy 
was taken, which revealed the presence of an infiltrate of chro-
nic lymphocytic leukemia (immunohistochemistry showed the 
presence of antigens CD20 (+), CD5 (+), CD23 (+), bcl2 (+), and 
the Ki-67 proliferative activity equaled 15-20%) and the patient 
was sent to the Clinic of Hematology for further treatment. 
Based on our case we would like to stress, that non-specific skin 
eruptions in the course of leukemias can cause great diagnostic 
difficulties due to the large variety.
SQUamoUS cell caRcINoma aRISINg oN INgUINal 
hIdRadeNItIS SUPPURatIva
Vera Leitão, Tomáš Pospíšil
Dermatology Department, Karlovarská Krajská Nemocnice, Karlovy Vary, 
Czech Republic
introduction: Hidradenitis suppurativa is a chronic inflam-
matory skin disorder characterized by recurrent formation of 
abscesses and scarring on the skin. Long-standing infection 
and abscess formation results in ulcers, fistulas and progressive 
scars. Squamous cell carcinoma is considered the most severe 
complication of HS.
case report: A 48-year-old man was referred to our clinic with 
a 20 year history of HS ocasionally treated with surgical incisions 
and oral antibiotics. His gluteal fistulas had started 20 years ago, 
his inguinal fistulas 10 years ago and in the previous 8 months, 
he had developed a large inguinal mass. Physical examination 
revealed a 20 × 5 cm irregular, wart-like ulcerative mass on his 
left groin area. Histopathological examination of skin biopsy 
showed features of invasive SCC. Radical resection of the tumor 
was not possible due to local dimensions and organs nearby. 
2 cycles of radiotherapy were performed. 6 months later the 
patient was hospitalized in our clinic with fever and signs of 
sepsis. CT and PET/CT were performed and revealed metastasis 
to the pelvic bone with osteomyelitis on the top. The patient 
refused bone biopsy for confirmation and staging of the dise-
ase, he was then transferred to a hospice where he is currently 
receiving palliative care. Oncologists ended the case with a bad 
prognosis and no indication for further chemo or radiotherapy.
Key message: Misdiagnosis and inadaquate treatment com-
plicate the progressive course of the disease. SCC in HS is rare, 
but mortality is high.
